Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

NCT01849328 is registered in ClinicalTrials.gov with Rauscher, Gregory E., M.D. PA as lead sponsor.

NCT NCT01849328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01849328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air
Lead sponsor
Rauscher, Gregory E., M.D. PA
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2013
Completion date
Not reported
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer